Harvard Bioscience last week reported a slight year-over-year increase in revenues for the first quarter, and turned a small net loss into a small profit.

Total revenues for the quarter increased to $22.4 million, up 1 percent from $22.2 million during the same quarter last year. The company's net income was $200,000, or $.01 per share, compared to a net loss of $51,000 during Q1 of 2004.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.